Interleukin-6 promotes the migration and invasion of nasopharyngeal carcinoma cell lines and upregulates the expression of MMP-2 and MMP-9

被引:89
作者
Sun, Wei [1 ]
Liu, Dong-Bo [1 ]
Li, Wen-Wen [1 ]
Zhang, Lin-Li [1 ]
Long, Guo-Xian [1 ]
Wang, Jun-Feng [1 ]
Mei, Qi [1 ]
Hu, Guo-Qing [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Oncol, Wuhan 430030, Hubei, Peoples R China
基金
中国国家自然科学基金;
关键词
interleukin-6; nasopharyngeal carcinoma; migration; invasion; MMP-2; MMP-9; EPSTEIN-BARR-VIRUS; ANTI-INTERLEUKIN-6; MONOCLONAL-ANTIBODY; IN-VITRO MODULATION; MULTIPLE-MYELOMA; EPITHELIAL-CELLS; OVARIAN-CANCER; LUNG-CANCER; MATRIX METALLOPROTEINASES; SERUM INTERLEUKIN-6; PRECLINICAL MODELS;
D O I
10.3892/ijo.2014.2323
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Nasopharyngeal carcinoma (NPC) shows the highest invasive and metastatic features among head and neck cancers. Distant metastasis remains the predominant mode of treatment failure in NPC patients. The role of interleukin-6 (IL-6) in NPC progression is not fully understood. In this study, we explored whether IL-6 could promote the migration and invasion activity of NPC cell lines, as well as whether the effect of IL-6 on cell migration and invasion is mediated through regulating the expression of matrix metal-loproteinase-2 (MMP-2) and MMP-9. Our results revealed that IL-6 and its receptors are broadly expressed in various NPC cell lines including HNE1, HONE1, CNE1, CNE1-LMP1 and 5-8F. Exogenous IL-6 enhanced cell proliferation slightly, but promoted cell migration and invasion significantly in both HNE1 and CNE1-LMP1 cell lines. In addition, an elevation in the expression of MMP-2 and MMP-9 could be induced by IL-6 stimulation. On the contrary, combining treatment with monoclonal anti-human IL-6R antibody (anti-IL-6R mAb) resulted in decreased proliferation, migration and invasion capabilities of NPC cells. Anti-IL-6R mAb also inhibited the expression of MMP-2 and MMP-9 in IL-6-stimulated HNE1 and CNE1-LMP1 cells. In summary, our data suggested that IL-6 mainly promotes the cell migration and invasion of NPC cells. The effect of IL-6 on cell migration and invasion may be mediated through regulation of the expression of MMP-2 and MMP-9. Thus, IL-6 or its related signaling pathways may be a promising target for preventing and inhibiting NPC metastasis.
引用
收藏
页码:1551 / 1560
页数:10
相关论文
共 61 条
[1]   Interleukin-6 in bone metastasis and cancer progression [J].
Ara, Tasnim ;
DeClerck, Yves A. .
EUROPEAN JOURNAL OF CANCER, 2010, 46 (07) :1223-1231
[2]   Inhibition of the IL-6 signaling pathway: A strategy to combat chronic inflammatory diseases and cancer [J].
Ataie-Kachoie, Parvin ;
Pourgholami, Mohammad H. ;
Morris, David L. .
CYTOKINE & GROWTH FACTOR REVIEWS, 2013, 24 (02) :163-173
[3]   Nasopharyngeal carcinoma [J].
Chan, A. T. C. .
ANNALS OF ONCOLOGY, 2010, 21 :308-312
[4]   Current treatment of nasopharyngeal carcinoma [J].
Chan, Anthony T. C. .
EUROPEAN JOURNAL OF CANCER, 2011, 47 :S302-S303
[5]   Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapy [J].
Chang, Chin Hao ;
Hsiao, Chin Fu ;
Yeh, Yu Min ;
Chang, Gee Chen ;
Tsai, Ying Huang ;
Chen, Yuh Min ;
Huang, Ming Shyan ;
Chen, Hui Ling ;
Li, Yao Jen ;
Yang, Pan Chyr ;
Chen, Chien Jen ;
Hsiung, Chao A. ;
Su, Wu Chou .
INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (09) :1977-1985
[6]   MULTIPLEXED IMMUNOBEAD-BASED PROFILING OF CYTOKINE MARKERS FOR DETECTION OF NASOPHARYNGEAL CARCINOMA AND PROGNOSIS OF PATIENT SURVIVAL [J].
Chang, Kai-Ping ;
Chang, Ya-Ting ;
Wu, Chih-Ching ;
Liu, Yu-Ling ;
Chen, Min-Chi ;
Tsang, Ngan-Ming ;
Hsu, Cheng-Lung ;
Chang, Yu-Sun ;
Yu, Jau-Song .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2011, 33 (06) :886-897
[7]   A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus [J].
Chen, HL ;
Hutt-Fletcher, L ;
Cao, L ;
Hayward, SD .
JOURNAL OF VIROLOGY, 2003, 77 (07) :4139-4148
[8]  
Chow KC, 2003, ONCOL REP, V10, P813
[9]   Inflammation and cancer [J].
Coussens, LM ;
Werb, Z .
NATURE, 2002, 420 (6917) :860-867
[10]  
Du CW, 2005, EXP ONCOL, V27, P267